Gottlieb Unlikely To Make Major Changes Right Away, Former Official Says

New US FDA commissioners have a lot of housekeeping to do before they can get to the fun stuff, according to former associate commissioner Wayne Pines.

FDA entrance sign 2016

US FDA Commissioner Scott Gottlieb has used his first weeks in office to signal that the agency will be taking significant steps on drug pricing and the use of opioids. But even as he aims for bold policy changes, at least for a while Gottlieb will be consumed by more prosaic tasks, according to Wayne Pines, health care president at APCO Worldwide and former associate commissioner for public affairs.

“Admittedly, this administration is somewhat more chaotic and somewhat less directive than previous administrations – actually, by far – but...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership